Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
Public ClinicalTrials.gov record NCT05796453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-term Evaluation of Safety and Performance of Clareon Presbyopia-Correcting Intraocular Lenses (IOLs)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Study identification
- NCT ID
- NCT05796453
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 470 participants
Conditions and interventions
Conditions
Interventions
- Clareon Vivity IOL - Non Toric Device
- Clareon Vivity IOL - Toric Device
- Clareon PanOptix Trifocal IOL - Non Toric Device
- Clareon PanOptix Trifocal IOL - Toric Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2023
- Primary completion
- Aug 20, 2026
- Completion
- Aug 20, 2026
- Last update posted
- Sep 1, 2026
2023 – 2026
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wolstan & Goldberg Eye Associates | Torrance | California | 90505 | — |
| Levenson Eye Associates | Jacksonville | Florida | 32204 | — |
| Eye Surgeons of CNY | Liverpool | New York | 13088 | — |
| Tulsa Ophthalmology | Tulsa | Oklahoma | 74104 | — |
| Chu Eye Institute | Fort Worth | Texas | 76107 | — |
| The Eye Institute of Utah | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05796453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05796453 live on ClinicalTrials.gov.